Developer docs
API playgroundTry for free, no card

Search company profiles

Fundacion Isabel Gemio

Full company profile

uuid004gmas

Namestring
Fundacion Isabel Gemio
Legal namestring
FUNDACIÓN ISABEL GEMIO
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Fundación Isabel Gemio is a Spanish non-profit foundation established in 2008 and headquartered in Madrid, dedicated to promoting and financing scientific, clinical, and basic research on muscular dystrophies and rare diseases. Founded by journalist Isabel Gemio, whose son lives with Duchenne muscular dystrophy, the foundation operates a dual mission of funding biomedical research lines and raising social awareness for affected patients and families. Its core activity consists of grantmaking to Spanish and European research institutions, complemented by European Union co-funded Erasmus+ projects focused on educational inclusion for people with rare diseases.

The foundation's operational offerings include a research funding program (cumulative contributions of €2,872,200 reported), an online donation platform supporting Bizum, PayPal, bank transfer, and phone-based giving with an 80% Spanish tax deduction, and three active Erasmus+ projects (VET for Inclusion, Educational Kits for Rare Diseases, and youth mentorship). It disseminates scientific publications from funded research lines and operates a multi-channel media presence (Facebook, Twitter/X, YouTube, LinkedIn, Instagram) to drive donations and awareness.

Revenue is generated exclusively through donations (individual and corporate), charity events, solidarity restaurant partnerships, and EU grant co-funding. The organization runs with approximately 5 employees and partners with a dense ecosystem that includes CSIC, IIS La Fe, Federación ASEM, Fundación ONCE, Fundación La Caixa, Telefónica, and Alexion. As a registered Spanish foundation (CIF G 85451433, Registry Nº1059), it does not sell commercial products; its 'customers' are beneficiaries (patients and families) and donors, with research institutions acting as funded grantees rather than paying clients.

Short descriptiontext

Fundación Isabel Gemio is a Madrid-based Spanish non-profit founded in 2008 that funds biomedical research on muscular dystrophies and rare diseases, primarily through donations and EU Erasmus+ grants, serving affected patients, families, and partnered research institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMadrid, Spain
HQ citystring
Madrid
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease research, muscular dystrophy funding, non-profit foundation, medical research grants, disease awareness campaigns
Industry3 codes
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAA
Private Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPADAOAB
Grantmaking & Philanthropic Funds (Institutional Donors)
Business & Public Services/International Organizations & Development/Donor Coordination, Grantmaking & Development Finance Programs
NAICS code3 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
SIC code1 code
  • Services-Social Services8300
Product category
Rare Disease Research Foundation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Donations and Fundraising
TypeGrants Donations
Description

The foundation generates revenue primarily through donations from individuals and corporations. Donors receive 80% tax deduction on their contributions. The foundation also organizes charity events, solidarity restaurants, and fundraising campaigns such as Bizum donations.

fundacionisabelgemio.com
2Erasmus+ Project Funding
TypeGrants Donations
Description

European Union co-funded projects through the Erasmus+ program that support educational inclusion for people with rare diseases.

fundacionisabelgemio.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1One-time or recurring monetary donations from individuals and organizations
ModelOtherBilling cadenceMonthly
Notes

Donation amounts: 10€, 20€, 50€, 100€, 200€, 500€, 1000€ or custom amount. 80% tax deduction available for Spanish donors.

fundacionisabelgemio.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Fundación Isabel Gemio is a non-profit foundation that funds biomedical research into muscular dystrophies and rare diseases, raises public awareness through campaigns such as "Todos Somos Raros," and supports affected families. It redistributes donations collected via website, bank transfer, PayPal, Bizum, and phone to accredited research projects, and runs complementary programs including an Erasmus+ educational exchange and scientific publications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 2,872,200 € contributed to research lines
+1 more record
Product overview1 text field

Fundación Isabel Gemio is a non-profit foundation that operates as a research funding organization rather than a traditional technology product company. The organization offers research project funding services, manages European educational programs (Erasmus+), provides a newsletter subscription service, and maintains a donation platform for supporting rare disease research. Key offerings include the Todos Somos Raros public research call initiative, VET for Inclusion and other Erasmus+ educational programs for people with rare diseases, and scientific publication dissemination. The foundation's core mission centers on financing muscular dystrophy and rare disease research rather than developing commercial software products.

Product and service4 records
1Research Grant Program for Muscular Dystrophies and Rare Diseases
CategoryBiomedical research funding
Description

Distributes donated funds to biomedical research projects on muscular dystrophies and rare diseases, in support of accredited researchers seeking to advance understanding and treatment of these conditions.

2Todos Somos Raros awareness campaign
CategoryDisease awareness campaign
Description

Public awareness initiative that increases visibility of rare diseases and the patients and families affected, designed to mobilize supporters and educate the broader Spanish public.

3Erasmus+ educational exchange program
CategoryResearcher education and training
Description

Educational exchange program associated with the foundation's research mission, supporting training and international collaboration among researchers and stakeholders in the rare disease field.

4Newsletter and scientific publications
CategoryCommunications and scientific publications
Description

Newsletter and scientific publication series that communicates research progress, foundation activities, and rare disease information to donors, patients, families, and the broader public.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
1Fundación Escuela de los Oficios
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-14
Description

Partner in Erasmus+ VET for Inclusion project for vocational training development.

fundacionisabelgemio.com
2Universidade de Évora
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-14
Description

European academic partner in Erasmus+ VET for Inclusion project.

fundacionisabelgemio.com
3Cyprus Alliance for Rare Disorders
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-14
Description

European partner in Erasmus+ project for rare disease inclusion in vocational training.

fundacionisabelgemio.com
4Rare Diseases Croatia
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-14
Description

European partner in Erasmus+ project for rare disease inclusion in vocational training.

fundacionisabelgemio.com
5Consejo Superior de Investigaciones Científicas (CSIC)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-13
Description

Collaboration through CSIC's Itinerario Cicerón program, participating in jornadas on rare diseases. CSIC researchers present ongoing rare disease research projects.

fundacionisabelgemio.com
6CSIC
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with CSIC institutions including CNB, CIB, and IIS La Fe for rare disease research.

fundacionisabelgemio.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborating entity supporting disability and rare disease initiatives.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Major Spanish banking foundation supporting social causes and research.

9Federación ASEM
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spanish Federation of Neuromuscular Diseases - key patient organization partner.

fundacionisabelgemio.com
Strategic tierMinorTypeOthers
Description

Telecommunications company supporting foundation activities.

11Fundación Starlite
Strategic tierMinorTypeOthers
Description

Foundation supporting charitable initiatives.

fundacionisabelgemio.com
Strategic tierMinorTypeOthers
Description

Pharmaceutical company specializing in rare diseases.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health Research Institute La Fe in Valencia - key research collaborator. Research projects on Duchenne and Becker muscular dystrophies conducted here.

14Grupo Park / CIBERNED
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research group studying molecular mechanisms in neurodegenerative diseases, part of CIBERNED network. Published study on myotonic dystrophy type I in Cells journal.

fundacionisabelgemio.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Federación Española de Enfermedades Raras (FEDER)
TypeDirect peer
Description

National Spanish federation representing the rare disease patient community. Operates with the same donation and grantmaking model, addresses overlapping beneficiaries, and competes for the same Spanish rare disease donor pool.

TypeDirect peer
Description

Spanish patient association specifically focused on Duchenne and Becker muscular dystrophies — the same conditions highlighted in Fundación Isabel Gemio's funded research lines. Direct overlap in mission and beneficiary base.

TypeBroad incumbent
Description

Large US-based nonprofit funding neuromuscular disease research and patient services. Comparable mission across muscular dystrophies but much larger scale and primarily US-focused.

TypeEmerging player
Description

European non-governmental alliance of rare disease patient organizations. Comparable European rare disease advocacy and grantmaking scope, operating at a federated level overlapping with FIG's Erasmus+ rare disease work.

TypeOthers
Description

Pharmaceutical company specializing in rare diseases, listed as a corporate sponsor of the foundation. Comparable focus on rare neuromuscular diseases but as a commercial drug developer rather than a grantmaking foundation.

TypeDirect peer
Description

Spanish disability foundation supporting people with disabilities including rare diseases. Listed as a collaborating entity with Fundación Isabel Gemio and competes for Spanish corporate and institutional disability funding.

TypeBroad incumbent
Description

One of Spain's largest philanthropic foundations, a major banking-related foundation supporting social causes and research. Listed as a supporting partner and operates as a much larger incumbent in the same Spanish grantmaking landscape.

TypeRegional player
Description

Leading US-based nonprofit focused on Duchenne muscular dystrophy research and advocacy. Comparable mission and grantmaking model, but operates primarily in the United States rather than Spain.

TypeEmerging player
Description

Spanish biomedical research network on rare diseases funded by Instituto de Salud Carlos III. Comparable focus on rare disease research in Spain and an indirect recipient/partner of foundation-funded research lines.

10Federación ASEM
TypeDirect peer
Description

Spanish Federation of Neuromuscular Diseases, a national patient umbrella organization. Listed as a core partner of Fundación Isabel Gemio and addresses the same patient population (muscular dystrophies and rare neuromuscular diseases) in Spain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fundacion Isabel Gemio

Rare Disease Research Foundationfundacionisabelgemio.com

Fundación Isabel Gemio is a Madrid-based Spanish non-profit founded in 2008 that funds biomedical research on muscular dystrophies and rare diseases, primarily through donations and EU Erasmus+ grants, serving affected patients, families, and partnered research institutions.

What Fundacion Isabel Gemio does

Fundación Isabel Gemio is a Spanish non-profit foundation established in 2008 and headquartered in Madrid, dedicated to promoting and financing scientific, clinical, and basic research on muscular dystrophies and rare diseases. Founded by journalist Isabel Gemio, whose son lives with Duchenne muscular dystrophy, the foundation operates a dual mission of funding biomedical research lines and raising social awareness for affected patients and families. Its core activity consists of grantmaking to Spanish and European research institutions, complemented by European Union co-funded Erasmus+ projects focused on educational inclusion for people with rare diseases.

The foundation's operational offerings include a research funding program (cumulative contributions of €2,872,200 reported), an online donation platform supporting Bizum, PayPal, bank transfer, and phone-based giving with an 80% Spanish tax deduction, and three active Erasmus+ projects (VET for Inclusion, Educational Kits for Rare Diseases, and youth mentorship). It disseminates scientific publications from funded research lines and operates a multi-channel media presence (Facebook, Twitter/X, YouTube, LinkedIn, Instagram) to drive donations and awareness.

Revenue is generated exclusively through donations (individual and corporate), charity events, solidarity restaurant partnerships, and EU grant co-funding. The organization runs with approximately 5 employees and partners with a dense ecosystem that includes CSIC, IIS La Fe, Federación ASEM, Fundación ONCE, Fundación La Caixa, Telefónica, and Alexion. As a registered Spanish foundation (CIF G 85451433, Registry Nº1059), it does not sell commercial products; its 'customers' are beneficiaries (patients and families) and donors, with research institutions acting as funded grantees rather than paying clients.

Fundacion Isabel Gemio firmographics

Firmographics
Name
Fundacion Isabel Gemio
Legal name
FUNDACIÓN ISABEL GEMIO
Website
https://fundacionisabelgemio.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
1–10 employees
Short description
Fundación Isabel Gemio is a Madrid-based Spanish non-profit founded in 2008 that funds biomedical research on muscular dystrophies and rare diseases, primarily through donations and EU Erasmus+ grants, serving affected patients, families, and partnered research institutions.
Ownership category
akta.pro rank

Fundacion Isabel Gemio industry classification

Industry
Product category
Rare Disease Research Foundation
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
SIC
Services-Social Services (8300)
akta.pro industry
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAA
Private Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPADAOAB
Grantmaking & Philanthropic Funds (Institutional Donors)
Business & Public Services/International Organizations & Development/Donor Coordination, Grantmaking & Development Finance Programs

Keywords

  • Rare disease research
  • Muscular dystrophy funding
  • Non-profit foundation
  • Medical research grants
  • Disease awareness campaigns

Where Fundacion Isabel Gemio is headquartered

Location

Headquarters

HQ city
Madrid
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Fundacion Isabel Gemio business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Donations and Fundraising: The foundation generates revenue primarily through donations from individuals and corporations. Donors receive 80% tax deduction on their contributions. The foundation also organizes charity events, solidarity restaurants, and fundraising campaigns such as Bizum donations.
  2. Erasmus+ Project Funding: European Union co-funded projects through the Erasmus+ program that support educational inclusion for people with rare diseases.

Pricing tiers

ModelBillingPrice
OtherMonthlyOne-time or recurring monetary donations from individuals and organizations

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Fundacion Isabel Gemio product offering

Product offering

Core offering

Fundación Isabel Gemio is a non-profit foundation that funds biomedical research into muscular dystrophies and rare diseases, raises public awareness through campaigns such as "Todos Somos Raros," and supports affected families. It redistributes donations collected via website, bank transfer, PayPal, Bizum, and phone to accredited research projects, and runs complementary programs including an Erasmus+ educational exchange and scientific publications.

Product overview

Fundación Isabel Gemio is a non-profit foundation that operates as a research funding organization rather than a traditional technology product company. The organization offers research project funding services, manages European educational programs (Erasmus+), provides a newsletter subscription service, and maintains a donation platform for supporting rare disease research. Key offerings include the Todos Somos Raros public research call initiative, VET for Inclusion and other Erasmus+ educational programs for people with rare diseases, and scientific publication dissemination. The foundation's core mission centers on financing muscular dystrophy and rare disease research rather than developing commercial software products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research Grant Program for Muscular Dystrophies and Rare Diseases Distributes donated funds to biomedical research projects on muscular dystrophies and rare diseases, in support of accredited researchers seeking to advance understanding and treatment of these conditions.
  • Todos Somos Raros awareness campaign Public awareness initiative that increases visibility of rare diseases and the patients and families affected, designed to mobilize supporters and educate the broader Spanish public.
  • Erasmus+ educational exchange program Educational exchange program associated with the foundation's research mission, supporting training and international collaboration among researchers and stakeholders in the rare disease field.
  • Newsletter and scientific publications Newsletter and scientific publication series that communicates research progress, foundation activities, and rare disease information to donors, patients, families, and the broader public.

Quantifiable outcome

  • 2,872,200 € contributed to research lines
  • +1 more outcomes

Companies that use Fundacion Isabel Gemio

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Fundacion Isabel Gemio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Fundacion Isabel Gemio partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and minor.

  • Fundación Escuela de los OficioscoreStrategic or Co-development Partner · 14 July 2025Partner in Erasmus+ VET for Inclusion project for vocational training development.
  • Universidade de ÉvoracoreStrategic or Co-development Partner · 14 July 2025European academic partner in Erasmus+ VET for Inclusion project.
  • Cyprus Alliance for Rare DisorderscoreStrategic or Co-development Partner · 14 July 2025European partner in Erasmus+ project for rare disease inclusion in vocational training.
  • Rare Diseases CroatiacoreStrategic or Co-development Partner · 14 July 2025European partner in Erasmus+ project for rare disease inclusion in vocational training.
  • Consejo Superior de Investigaciones Científicas (CSIC)coreStrategic or Co-development Partner · 13 June 2025Collaboration through CSIC's Itinerario Cicerón program, participating in jornadas on rare diseases. CSIC researchers present ongoing rare disease research projects.
  • CSICcoreStrategic or Co-development PartnerResearch collaboration with CSIC institutions including CNB, CIB, and IIS La Fe for rare disease research.
  • Fundación ONCEminorStrategic or Co-development PartnerCollaborating entity supporting disability and rare disease initiatives.
  • Fundación Bancaria La CaixaminorStrategic or Co-development PartnerMajor Spanish banking foundation supporting social causes and research.
  • Federación ASEMcoreStrategic or Co-development PartnerSpanish Federation of Neuromuscular Diseases - key patient organization partner.
  • TelefónicaminorOthersTelecommunications company supporting foundation activities.
  • Fundación StarliteminorOthersFoundation supporting charitable initiatives.
  • AlexionminorOthersPharmaceutical company specializing in rare diseases.
  • IIS La FecoreStrategic or Co-development PartnerHealth Research Institute La Fe in Valencia - key research collaborator. Research projects on Duchenne and Becker muscular dystrophies conducted here.
  • Grupo Park / CIBERNEDcoreStrategic or Co-development PartnerResearch group studying molecular mechanisms in neurodegenerative diseases, part of CIBERNED network. Published study on myotonic dystrophy type I in Cells journal.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Fundacion Isabel Gemio competitors and assessment

Company assessment

Direct peers

  • Federación Española de Enfermedades Raras (FEDER): National Spanish federation representing the rare disease patient community. Operates with the same donation and grantmaking model, addresses overlapping beneficiaries, and competes for the same Spanish rare disease donor pool.
  • Duchenne Parent Project España: Spanish patient association specifically focused on Duchenne and Becker muscular dystrophies — the same conditions highlighted in Fundación Isabel Gemio's funded research lines. Direct overlap in mission and beneficiary base.
  • Fundación ONCE: Spanish disability foundation supporting people with disabilities including rare diseases. Listed as a collaborating entity with Fundación Isabel Gemio and competes for Spanish corporate and institutional disability funding.
  • Federación ASEM: Spanish Federation of Neuromuscular Diseases, a national patient umbrella organization. Listed as a core partner of Fundación Isabel Gemio and addresses the same patient population (muscular dystrophies and rare neuromuscular diseases) in Spain.

Broad incumbents

  • Muscular Dystrophy Association (MDA): Large US-based nonprofit funding neuromuscular disease research and patient services. Comparable mission across muscular dystrophies but much larger scale and primarily US-focused.
  • Fundación Bancaria La Caixa: One of Spain's largest philanthropic foundations, a major banking-related foundation supporting social causes and research. Listed as a supporting partner and operates as a much larger incumbent in the same Spanish grantmaking landscape.

Emerging players

  • EURORDIS - Rare Diseases Europe: European non-governmental alliance of rare disease patient organizations. Comparable European rare disease advocacy and grantmaking scope, operating at a federated level overlapping with FIG's Erasmus+ rare disease work.
  • CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras): Spanish biomedical research network on rare diseases funded by Instituto de Salud Carlos III. Comparable focus on rare disease research in Spain and an indirect recipient/partner of foundation-funded research lines.

Others

  • Alexion (AstraZeneca Rare Disease): Pharmaceutical company specializing in rare diseases, listed as a corporate sponsor of the foundation. Comparable focus on rare neuromuscular diseases but as a commercial drug developer rather than a grantmaking foundation.

Regional players

  • Parent Project Muscular Dystrophy (PPMD): Leading US-based nonprofit focused on Duchenne muscular dystrophy research and advocacy. Comparable mission and grantmaking model, but operates primarily in the United States rather than Spain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Fundacion Isabel Gemio social profiles

Digital presence

Fundacion Isabel Gemio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fundacion Isabel Gemio leadership team

Management profile

Number of profiles

Profiles1 record

Fundacion Isabel Gemio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fundacion Isabel Gemio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fundacion Isabel Gemio

What does Fundacion Isabel Gemio do?

Fundación Isabel Gemio is a non-profit foundation that funds biomedical research into muscular dystrophies and rare diseases, raises public awareness through campaigns such as "Todos Somos Raros," and supports affected families. It redistributes donations collected via website, bank transfer, PayPal, Bizum, and phone to accredited research projects, and runs complementary programs including an Erasmus+ educational exchange and scientific publications.

Is Fundacion Isabel Gemio a public or private company?

Fundacion Isabel Gemio is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Fundacion Isabel Gemio founded?

Fundacion Isabel Gemio was founded in 2008. It employs 1 to 10 people.

Where is Fundacion Isabel Gemio based?

Fundacion Isabel Gemio is headquartered in Madrid, Spain, in the Europe region.

How does Fundacion Isabel Gemio make money?

Two revenue lines are on record. Donations and Fundraising is the primary driver. The others are erasmus+ Project Funding.

Who are Fundacion Isabel Gemio's main competitors?

Direct peers on record are Federación Española de Enfermedades Raras (FEDER), Duchenne Parent Project España, Fundación ONCE and Federación ASEM. Broad incumbents are Muscular Dystrophy Association (MDA) and Fundación Bancaria La Caixa. Emerging players are EURORDIS - Rare Diseases Europe and CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras). Alexion (AstraZeneca Rare Disease) is listed as an others. Parent Project Muscular Dystrophy (PPMD) is listed as a regional player.

Does Fundacion Isabel Gemio have an API?

No public API is recorded for Fundacion Isabel Gemio.

What industry is Fundacion Isabel Gemio in?

Fundacion Isabel Gemio's product category is Rare Disease Research Foundation. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGAKAA, Private Foundations. Its NAICS code is 813211 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales